The Epoch Times By
Previous monoclonal antibody treatments against COVID-19 have had mixed results against variants. However, new research uncovered two antibodies that work against all known strains of COVID-19.
STORY AT-A-GLANCE
- Two antibodies have been uncovered that are so effective at neutralizing COVID-19 — and all of its variants — that they believe the antibodies could serve as an “effective substitute for vaccines”
- The antibodies — TAU-1109 and TAU-2310 — bind to a different area of the spike protein than other antibodies, one that doesn’t undergo many mutations
- TAU-1109 is 92% effective at neutralizing the omicron strain and 90% effective at neutralizing the delta strain
- TAU-2310 has an efficacy rate of 84% at neutralizing omicron and a 97% efficacy rate against the delta variant
- The researchers believe that with effective antibody treatment, “we will not have to provide booster doses to the entire population every time there is a new variant”
Researchers at Tel Aviv University revealed two antibodies that are so effective at neutralizing SARS-CoV-2 — and all of its variants — that they believe the antibodies could serve as an “effective substitute for vaccines.”1 One of the glaring failures surrounding COVID-19 shots is their lack of effectiveness against emerging COVID-19 strains.
By choosing the spike protein on which to base COVID-19 shots, scientists picked a protein that not only was known to be toxic to humans but was not the part of the virus that prompted the best immune response.
Spike protein mutates rapidly, which essentially destroys virtually any protection that the shot provides shortly after it’s given. The end result is a seemingly never-ending series of annual shots and boosters, which can only offer rapidly waning protection. If the Israeli researchers’ findings are verified and the antibodies turn out to be as effective as suspected, it could eliminate COVID-19 booster shots entirely.2
